327 related articles for article (PubMed ID: 17222314)
21. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
[TBL] [Abstract][Full Text] [Related]
22. Endoscopy/surveillance in inflammatory bowel disease.
Ahmadi AA; Polyak S
Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
[TBL] [Abstract][Full Text] [Related]
23. Chemoprevention of colorectal cancer in inflammatory bowel disease.
Subramanian V; Logan RF
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):593-606. PubMed ID: 22122774
[TBL] [Abstract][Full Text] [Related]
24. Patients with sporadic duodenal adenoma are a high-risk group for advanced colorectal neoplasia: results of a case-control study.
Pequin P; Manfredi S; Quentin V; Heresbach D; Boyer J; Siproudhis L; Bretagne JF
Aliment Pharmacol Ther; 2007 Jul; 26(2):277-82. PubMed ID: 17593073
[TBL] [Abstract][Full Text] [Related]
25. Paediatric inflammatory bowel disease during a 44-year period in Copenhagen County: occurrence, course and prognosis--a population-based study from the Danish Crohn Colitis Database.
Jakobsen C; Paerregaard A; Munkholm P; Wewer V
Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1291-301. PubMed ID: 19581873
[TBL] [Abstract][Full Text] [Related]
26. Proton pump inhibitors and the risk of colorectal cancer.
van Soest EM; van Rossum LG; Dieleman JP; van Oijen MG; Siersema PD; Sturkenboom MC; Kuipers EJ
Am J Gastroenterol; 2008 Apr; 103(4):966-73. PubMed ID: 18070237
[TBL] [Abstract][Full Text] [Related]
27. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk.
Rutter MD; Saunders BP; Wilkinson KH; Rumbles S; Schofield G; Kamm MA; Williams CB; Price AB; Talbot IC; Forbes A
Gut; 2004 Dec; 53(12):1813-6. PubMed ID: 15542520
[TBL] [Abstract][Full Text] [Related]
28. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
Broomé U; Bergquist A
Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
[TBL] [Abstract][Full Text] [Related]
29. Congenital esotropia in Olmsted County, Minnesota.
Mohney BG; Erie JC; Hodge DO; Jacobsen SJ
Ophthalmology; 1998 May; 105(5):846-50. PubMed ID: 9593385
[TBL] [Abstract][Full Text] [Related]
30. Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.
Chan EP; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Sep; 35(3):675-712. PubMed ID: 16952746
[TBL] [Abstract][Full Text] [Related]
31. Clinical study of the relationship between inflammatory bowel diseases and colorectal neoplasms.
Zhao YJ; Yuan YZ
J Dig Dis; 2009 May; 10(2):113-7. PubMed ID: 19426393
[TBL] [Abstract][Full Text] [Related]
32. [Colorectal cancer in inflammatory bowel disease].
Henriksen M; Moum B
Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155
[TBL] [Abstract][Full Text] [Related]
33. Sporadic duodenal adenoma and the association with colorectal neoplasia: a case-control study.
Ramsoekh D; van Leerdam ME; Dekker E; Ouwendijk RT; van Dekken H; Kuipers EJ
Am J Gastroenterol; 2008 Jun; 103(6):1505-9. PubMed ID: 18510617
[TBL] [Abstract][Full Text] [Related]
34. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota.
Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ
Inflamm Bowel Dis; 2006 Aug; 12(8):669-76. PubMed ID: 16917220
[TBL] [Abstract][Full Text] [Related]
35. Surveillance for cancer and dysplasia in inflammatory bowel disease.
Rubin DT; Kavitt RT
Gastroenterol Clin North Am; 2006 Sep; 35(3):581-604. PubMed ID: 16952742
[TBL] [Abstract][Full Text] [Related]
36. Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis.
Imam MH; Thackeray EW; Lindor KD
Colorectal Dis; 2013 Feb; 15(2):198-203. PubMed ID: 22712545
[TBL] [Abstract][Full Text] [Related]
37. Review article: The relevance of surveillance endoscopy in long-lasting inflammatory bowel disease.
Vleggaar FP; Lutgens MW; Claessen MM
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():47-52. PubMed ID: 18081648
[TBL] [Abstract][Full Text] [Related]
38. Infliximab for inflammatory bowel disease in Denmark 1999-2005: clinical outcome and follow-up evaluation of malignancy and mortality.
Caspersen S; Elkjaer M; Riis L; Pedersen N; Mortensen C; Jess T; Sarto P; Hansen TS; Wewer V; Bendtsen F; Moesgaard F; Munkholm P;
Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1212-7; quiz 1176. PubMed ID: 18848503
[TBL] [Abstract][Full Text] [Related]
39. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
40. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors.
Cottet V; Pariente A; Nalet B; Lafon J; Milan C; Olschwang S; Bonaiti-Pellié C; Faivre J; Bonithon-Kopp C;
Gastroenterology; 2007 Oct; 133(4):1086-92. PubMed ID: 17919484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
